Infichem Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 11-12-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.50 Cr
as on 11-12-2024
- Revenue 3.81%
(FY 2023)
- Profit -47.34%
(FY 2023)
- Ebitda -42.43%
(FY 2023)
- Net Worth 27.17%
(FY 2023)
- Total Assets -4.70%
(FY 2023)
About Infichem Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹8.50 Cr.
Ashvinkumar Patel, Krishna Vashi, and Parv Desai serve as directors at the Company.
- CIN/LLPIN
U24239GJ2019PTC106239
- Company No.
106239
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Infichem Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashvinkumar Patel  | Director | 24-Jan-2019 | Current |
| Krishna Vashi | Director | 30-Nov-2021 | Current |
| Parv Desai | Director | 22-Jun-2020 | Current |
Financial Performance of Infichem Pharma.
Infichem Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.81% increase. The company also saw a substantial fall in profitability, with a 47.34% decrease in profit. The company's net worth Soared by an impressive increase of 27.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Infichem Pharma?
In 2023, Infichem Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jun 2021 | ₹8.50 Cr | Open |
How Many Employees Work at Infichem Pharma?
Infichem Pharma has a workforce of 12 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Infichem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infichem Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
